| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.650 | 20.954 | 31.116 | 49.224 | 47.473 | 36.804 | 115.213 | 154.413 | 176.021 | 181.536 |
| Total Income - EUR | 22.483 | 25.741 | 31.214 | 54.902 | 50.198 | 36.847 | 115.256 | 154.479 | 185.752 | 181.573 |
| Total Expenses - EUR | 28.485 | 25.198 | 23.116 | 46.472 | 36.063 | 36.415 | 34.785 | 130.179 | 118.933 | 133.712 |
| Gross Profit/Loss - EUR | -6.002 | 543 | 8.099 | 8.430 | 14.136 | 432 | 80.471 | 24.300 | 66.819 | 47.861 |
| Net Profit/Loss - EUR | -6.591 | 124 | 7.787 | 7.935 | 13.662 | 70 | 79.319 | 22.756 | 65.242 | 44.062 |
| Employees | 2 | 0 | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 4 |
Check the financial reports for the company - Vespira Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.595 | 5.034 | 15.328 | 28.730 | 27.168 | 25.969 | 28.301 | 49.217 | 64.330 | 56.376 |
| Current Assets | 14.034 | 9.128 | 16.035 | 22.102 | 21.145 | 21.361 | 74.132 | 44.802 | 38.033 | 38.596 |
| Inventories | 8.346 | 2.698 | 7.242 | 10.874 | 12.565 | 12.345 | 35.863 | 12.047 | 12.511 | 12.456 |
| Receivables | 3.749 | 6.227 | 7.160 | 10.219 | 8.234 | 3.074 | 16.819 | 20.438 | 17.327 | 22.718 |
| Cash | 1.939 | 203 | 1.633 | 1.009 | 347 | 5.942 | 21.450 | 12.317 | 8.195 | 3.422 |
| Shareholders Funds | -11.015 | -10.778 | -2.809 | 4.627 | 18.200 | 17.924 | 80.875 | 60.660 | 73.165 | 70.072 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 29.563 | 24.940 | 34.093 | 46.128 | 30.038 | 29.331 | 21.485 | 33.287 | 29.125 | 24.827 |
| Income in Advance | 81 | 80 | 79 | 77 | 76 | 74 | 73 | 73 | 73 | 72 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1082 - 1082" | |||||||||
| CAEN Financial Year |
1082
|
|||||||||
Comments - Vespira Plus Srl